- Home
- NVAX vs HEPS Comparison
NVAX vs HEPS Comparison
Compare NVAX & HEPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVAX
- HEPS
- Stock Information
- Founded
- NVAX 1987
- HEPS 2000
- Country
- NVAX United States
- HEPS Turkey
- Employees
- NVAX N/A
- HEPS N/A
- Industry
- NVAX Biotechnology: Biological Products (No Diagnostic Substances)
- HEPS Catalog/Specialty Distribution
- Sector
- NVAX Health Care
- HEPS Consumer Discretionary
- Exchange
- NVAX Nasdaq
- HEPS Nasdaq
- Market Cap
- NVAX 1.3B
- HEPS 1.1B
- IPO Year
- NVAX 1995
- HEPS 2021
- Fundamental
- Price
- NVAX $8.17
- HEPS $3.17
- Analyst Decision
- NVAX Buy
- HEPS
- Analyst Count
- NVAX 6
- HEPS 0
- Target Price
- NVAX $17.83
- HEPS N/A
- AVG Volume (30 Days)
- NVAX 4.7M
- HEPS 589.6K
- Earning Date
- NVAX 05-09-2025
- HEPS 03-24-2025
- Dividend Yield
- NVAX N/A
- HEPS N/A
- EPS Growth
- NVAX N/A
- HEPS N/A
- EPS
- NVAX N/A
- HEPS N/A
- Revenue
- NVAX $682,162,000.00
- HEPS $1,167,077,294.00
- Revenue This Year
- NVAX N/A
- HEPS $43.21
- Revenue Next Year
- NVAX $15.02
- HEPS $37.58
- P/E Ratio
- NVAX N/A
- HEPS N/A
- Revenue Growth
- NVAX N/A
- HEPS 82.39
- 52 Week Low
- NVAX $3.81
- HEPS $1.25
- 52 Week High
- NVAX $23.86
- HEPS $4.05
- Technical
- Relative Strength Index (RSI)
- NVAX 51.30
- HEPS 43.22
- Support Level
- NVAX $7.66
- HEPS $2.95
- Resistance Level
- NVAX $8.48
- HEPS $3.46
- Average True Range (ATR)
- NVAX 0.64
- HEPS 0.19
- MACD
- NVAX 0.08
- HEPS -0.03
- Stochastic Oscillator
- NVAX 71.43
- HEPS 37.04
About NVAX Novavax Inc.
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
About HEPS D-Market Electronic Services & Trading
D-MARKET Electronic Services & Trading offers an e-commerce platform in Turkey and the surrounding region. The company is comprised of one reportable segment, namely e-commerce operations. The Group derives revenue from the sales of goods, marketplace revenues, and other revenues.